UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$716M |
| 2 |
Amazon
AMZN
|
+$685M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$508M |
| 4 |
JPMorgan Chase
JPM
|
+$403M |
| 5 |
Costco
COST
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 2 |
UBS Group
UBS
|
+$1.5B |
| 3 |
TotalEnergies
TTE
|
+$1.08B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$651M |
| 5 |
Vanguard Total World Stock ETF
VT
|
+$444M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.65% |
| 2 | Financials | 6.89% |
| 3 | Healthcare | 6.2% |
| 4 | Consumer Discretionary | 5.88% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
CALL
Neurocrine Biosciences
NBIX
$16.2B
| $2.48M | ﹤0.01% |
+28,100
| New | +$2.35M |
|
|
BCIC
2802
BCP Investment Corp
BCIC
$91.5M
| $2.48M | ﹤0.01% |
68,401
+1,653
| +2% | +$58.7K |
|
2803
Silgan Holdings
SLGN
$4.39B
| $2.48M | ﹤0.01% |
83,522
+77,615
| +1,314% | +$2.14M |
|
2804
Murphy USA
MUSA
$9.9B
| $2.47M | ﹤0.01% |
28,887
-6,457
| -18% | -$510K |
|
2805
PBF Energy
PBF
$7.26B
| $2.47M | ﹤0.01% |
79,277
-175,496
| -69% | -$5.9M |
|
2806
Robert Half
RHI
$4.16B
| $2.46M | ﹤0.01% |
37,797
+6,095
| +19% | +$387K |
|
2807
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$775M
| $2.46M | ﹤0.01% |
124,760
-237,740
| -66% | -$4.59M |
|
2808
VanEck India Growth Leaders ETF
GLIN
$95M
| $2.46M | ﹤0.01% |
56,051
+34,693
| +162% | +$1.41M |
|
2809
Dr. Reddy's Laboratories
RDY
$10.1B
| $2.46M | ﹤0.01% |
303,075
-29,430
| -9% | -$224K |
|
2810
State Street SPDR NYSE Technology ETF
XNTK
$2.19B
| $2.45M | ﹤0.01% |
34,406
-4,253
| -11% | -$284K |
|
2811
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$426M
| $2.44M | ﹤0.01% |
40,025
-29,477
| -42% | -$1.69M |
|
|
DSM
2812
BNY Mellon Strategic Municipal Bond Fund
DSM
$291M
| $2.44M | ﹤0.01% |
315,859
+64,484
| +26% | +$483K |
|
2813
PUT
Las Vegas Sands
LVS
$29.9B
| $2.44M | ﹤0.01% |
40,000
-105,400
| -72% | -$6.21M |
|
2814
OFS Capital
OFS
$50.8M
| $2.44M | ﹤0.01% |
207,417
-3,233
| -2% | -$37.5K |
|
2815
Tredegar Corp
TG
$270M
| $2.44M | ﹤0.01% |
150,980
-5,028
| -3% | -$85.1K |
|
|
CNSL
2816
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $2.44M | ﹤0.01% |
223,207
+104,778
| +88% | +$1.1M |
|
|
MVC
2817
DELISTED
MVC Capital, Inc.
MVC
| $2.43M | ﹤0.01% |
268,138
-23,908
| -8% | -$217K |
|
2818
Atlanta Braves Holdings Series A
BATRA
$3.37B
| $2.43M | ﹤0.01% |
86,882
+8,079
| +10% | +$222K |
|
|
JHD
2819
DELISTED
Nuveen High Income December 2019 Target Term Fund
JHD
| $2.42M | ﹤0.01% |
244,737
+20,372
| +9% | +$202K |
|
2820
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $2.42M | ﹤0.01% |
253,499
+43,593
| +21% | +$401K |
|
|
RETA
2821
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.41M | ﹤0.01% |
28,221
+738
| +3% | +$61.3K |
|
2822
Fomento Económico Mexicano
FMX
$41.6B
| $2.41M | ﹤0.01% |
26,128
-5,537
| -17% | -$505K |
|
2823
Intellia Therapeutics
NTLA
$1.57B
| $2.41M | ﹤0.01% |
141,136
-63,465
| -31% | -$946K |
|
2824
CALL
NovoCure
NVCR
$1.83B
| $2.41M | ﹤0.01% |
+50,000
| New | +$2.41M |
|
2825
CALL
Electronic Arts
EA
| $2.4M | ﹤0.01% |
23,600
-39,000
| -62% | -$3.7M |
|
Similar funds
UBS Group's Q1 2019 Portfolio in Review
As of Q1 2019, UBS Group held 8,700 positions worth $242B, up 9.8% from $221B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $12.7B in Q1 2019, closing 903 positions and reducing 3,843 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $341M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in PIMCO Dynamic Income Strategy Fund worth $15.4M.
- UBS Group's largest Q1 2019 buy was PIMCO Dynamic Income Strategy Fund: 753,726 shares worth $15.4M.
- UBS Group added most to Microsoft in Q1 2019, an estimated $716M increase.
- UBS Group's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.53B.
- UBS Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $341M.
- UBS Group's ten largest holdings make up 15% of its $242B portfolio in Q1 2019.
- UBS Group opened 579 new positions and closed 903 in Q1 2019.
- UBS Group's portfolio value rose 9.8% quarter-over-quarter to $242B.
Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.